Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of 2012 Bioequivalence Standards for Narrow Therapeutic Index Drugs: a Study With Warfarin

NCT02574754 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02574754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02574754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of 2012 Bioequivalence Standards for Narrow Therapeutic Index Drugs: a Study With Warfarin
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2016
Completion date
February 28, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy